🤝 GARDP and @dndi.org are pleased to announce support from the Foundation for the Adaptation of International Geneva to strengthen collaboration, share capabilities and resources, and help both focus more on developing and ensuring access to treatments for NTDs and drug-resistant infections.

🌎 For the first time, GARDP is participating in the PAHO Directing Council, joining health authorities from across the Americas to discuss shared public health priorities. 💊Our work with PAHO is strengthening AMR surveillance, research and antibiotic access. 🎥See the work taking shape in LatAm.

🚀 #GAMRIC2026 kicks off in Lisbon For the next three days, people working across #AMR are coming together to talk about what is changing in the science, where the gaps remain, and what it will take to develop better tools against AMR. Come meet the team!

#GAMRIC2026 starts tomorrow! We are excited to welcome you to Lisbon, Portugal and hope you enjoy the innovative programme and opportunities to connect. Follow along over the next days as we cover highlights from the conference. LifeArc CARB-X Global Antibiotic R&D Partnership (GARDP)

#ACC2027 registration & abstract submissions are open! Join the free, virtual conference on #AMR jointly organised by @bsacandjac.bsky.social and GARDP with @eupohamr.bsky.social as collaborating organization for 2027. 🔗Register: tinyurl.com/mr2bftrv 👉Submit an abstract: tinyurl.com/bddwc49x

In Brazil, GARDP & Fiocruz are working with hospitals & labs to understand resistance profiles for the responsible use of Reserve antibiotics, including susceptibility to cefiderocol. Microbiologists recently trained at Fiocruz’s LABSUR for training in antimicrobial susceptibility testing.

1 WEEK TO GO | #GAMRIC2026 🗓️22–24 Sept 2026 📍Lisbon, Portugal In one week, researchers, academics and industry experts from around the world will meet at the 2nd Global AMR Innovators Conference (GAMRIC) 2026 to explore innovations addressing #AMR. 🔗Register now: www.gamric.org/registration...

Does your organization have insights into how AI can improve clinical trial design and documentation? MMV, @dndi.org and @gardp.bsky.social are mapping AI solutions for clinical study design, operations and medical writing. Submission deadline: 7 October Learn more: bit.ly/3UMwkeW

#FungalAwarenessWeek2026 | 2 days to go! Join #REVIVE on 17 Sept for our webinar exploring newer azoles, extended dosing, long half-life echinocandins and novel antifungals, with a live Q&A. attendee.gotowebinar.com/register/754...

Newly published GARDP-sponsored research offers encouraging evidence for expanding treatment options for newborns with sepsis. 🔗 pubmed.ncbi.nlm.nih.gov/42705380/ #AMR #GARDP

In vitro activity of flomoxef, fosfomycin and amikacin versus a global panel of third-generation cephalosporin-resistant Enterobacterales and prediction of their ability in pairwise combinations to work as carbapenem-sparing regimens - PubMed

The results confirm the potential of these combinations as carbapenem-sparing treatments and provide additional evidence to support the evaluation of these combinations in the neonatal sepsis trial that is sponsored by GARDP (ISRCTN48721236).

pubmed.ncbi.nlm.nih.gov

On #WorldSepsisDay, we’re reminded that treating sepsis depends on having antibiotics that work. As resistance grows, those options are shrinking. “Invest in Sepsis – Save Lives” means investing in the treatments we need to stay ahead. #AMRIsBig #OurResponseIsBigger

In Germany, earlier diagnosis helps patients receive treatment for sepsis sooner, but AMR is making infections harder to treat. Peter Beyer writes in Tagesspiegel Background on why sepsis investment must include new antibiotics: tinyurl.com/3pt7tama #WorldSepsisDay #AMRIsBig #OurResponseIsBigger

Sepsis: A race against time – and against resistance. – GARDP

11 September 2026 Published in the Tagesspiegel Background By Peter Beyer, Deputy Executive Director, the Global Antibiotic Research & Development Partnersh

gardp.org

Personalized phage therapy has strong biological promise. But making it part of routine #AMR care will depend on stronger infrastructure. A new #REVIVE viewpoint explores what it will take to scale. 🔗https://tinyurl.com/53y2pf54

💻 Register for #REVIVE’s 29 Sept webinar on clinical trial evidence shaping antibiotic use. ⏰29 Sept | 13:30 - 15:00 CEST attendee.gotowebinar.com/register/261... @jesusrbano.bsky.social I @clarityinitiative.bsky.social

STARTING 🔜 Join the #WorldSepsisDay webinar exploring how neonatal antimicrobial stewardship can improve antibiotic use today and help protect treatment options for tomorrow. GARDP’s Justin Green will be joining the expert discussion.

The Newborn Toolkit@newborntoolkit.bsky.social · 3w ago

🚨JOIN US TODAY for our online webinar marking World Sepsis in partnership with with PANSAA and NeoNET Africa! Neonatal Antimicrobial Stewardship: Today's Use, Tomorrow's Antibiotics 📆 8th September | 3pm EAT | 1pm WAT | 1pm BST | 8am EDT 🔗: newborntoolkit.org/webinars/wor...

New in @thelancet.com: the PediCAP trial brings important evidence on treating severe community-acquired pneumonia in young children in African hospitals. The trial used a novel design to examine IV-to-oral antibiotic step-down, antibiotic choice and more. 🔗 www.thelancet.com/journals/lan...

Oral step-down, optimal drug, and total duration of antibiotic treatment in African children hospitalised with severe community-acquired pneumonia (PediCAP): a factorial randomised controlled trial

For sub-Saharan African children hospitalised with severe CAP without complicating factors, a strategy of stepping down upon clinical improvement to oral amoxicillin after initial intravenous antibiot...

thelancet.com

Journalist Md Zahid Hossain Khan investigates AMR in Bangladesh’s ICUs and NICUs in a new Daily Sun feature. The story is part of GARDP’s first-ever #WithoutBordersMediaFellowship, supporting in-depth AMR reporting across South Asia. 🔗Read the full article here: www.daily-sun.com/health/89640...

What does a new antibiotic have to do with sexual health? More than you might think. As gonorrhoea becomes harder to treat, impact can reach reproductive health, pregnancy and newborns. That makes antibiotic innovation part of sexual health. 🦠 #AMRIsBIG #OurResponseIsBIGGER

📅 Save the date: 9–11 Feb 2027 The #ACC2027 is a free, open-access virtual conference, jointly organised by @bsacandjac.bsky.social and GARDP within the framework of the @eupohamr.bsky.social. More info coming soon! 🌐Explore the website: acc-conference.com

Developing a new antibiotic is only half the race. 🌍 But it's equally important that treatments reach the countries and communities with the greatest need, without unnecessary delays. 💊At GARDP, we believe antibiotic innovation and access must go hand in hand in the fight against #AMR.

Learn how public-private partnerships help facilitate drug development, advance research, provide financing and share risks in this REVIVE Encyclopaedia video featuring Clara Maure from GARDP. 🎥 revive.gardp.org/resource/pub... #AMR #REVIVE

What would happen if antibiotics stopped working? In a recent interview with GARDP, Dr. Norio Ohmagari discusses the growing threat of AMR, the challenges facing antibiotic development and the importance of global collaboration. 🔗Read the full interview: gardp.org/healthcare-i...

“Healthcare itself may cease to function” – GARDP

Dr. Norio Ohmagari on Japan’s AMR crisis and global challenges Dr. Norio Ohmagari is an infectious disease specialist and medical doctor. He serves as Director

gardp.org

🎙️Join us for AMR Discussions Webinar - Breaking the resistance: Empowering the next generation of antimicrobial researchers. 📅3 Sept | 🕒15:00–16:00 CEST Explore the shortage of specialised antimicrobial researchers & solutions to attract & retain talent. 👉 register.gotowebinar.com/register/298...

👶 A bigger response means putting children first Too often, children wait for evidence to guide antibiotic treatment. Together with @pentafoundation.bsky.social, we're helping close the evidence gap for children and ensure they are part of antibiotic development from the start.

swissinfo.ch takes a closer look at the strategic collaboration between @dndi.org, @mmv.org and GARDP as the global health landscape changes. 🔗Read here: www.swissinfo.ch/eng/new-trea...

On #WorldSepsisDay, join experts exploring how antimicrobial stewardship can strengthen neonatal care, improve antibiotic use and help address AMR. GARDP’s Justin Green will join the discussion. 📅 8 Sept | 3pm EAT | 1pm WAT | 1pm BST | 8am EDT 🔗 newborntoolkit.org/webinars/wor...

The Newborn Toolkit@newborntoolkit.bsky.social · 2mo ago

🚨 Join us for our World Sepsis Day Newborn Toolkit webinar! 📆 8th September | 3pm EAT | 1pm WAT | 1pm BST | 8am EDT 🔗 : newborntoolkit.org/webinars/wor...

GARDP & the South African Medical Research Council recently convened experts in Cape Town to help shape GARDP's Strategic Plan 2027-31. The discussion focused on South African priorities for developing & improving access to much-needed antibiotic treatments in the region. @samrcza.bsky.social

⏳ One month to go until #GAMRIC2026! Join the global AMR community in Lisbon for three days of discussions on breakthroughs in therapeutics, diagnostics, vaccines and preventatives addressing AMR. 📍 Lisbon, Portugal 📅 22–24 September 🔗 www.gamric.org

🎙️ Join our AMR Discussions webinar on 3 Sept (14:30-15:30 CEST) As expert researchers leave or retire, how can we attract and retain the talent needed to secure the future of antibiotic development? 🔗Register: attendee.gotowebinar.com/register/298...

🌍 Since 2018, REVIVE has helped bring together researchers from clinical, industry and academic settings to share expert #AMR knowledge. 📚 Through a growing library of free resources, REVIVE supports early-stage antimicrobial researchers. 🌐Explore everything #REVIVE has to offer: revive.gardp.org